8-K filed May 12, 2026 at 07:02 ET
Sleep Number reported Q1 2026 net sales of $319M, down 18.9% YoY, and a GAAP net loss of -$2.19 per share, significantly worse than the consensus estimate of -$0.47. Adjusted EBITDA collapsed 74% to $6M. The company is not providing guidance due to an ongoing strategic review, and its forward-looking statements explicitly reference going concern risk. The filing is bearish due to accelerating revenue decline, deepening losses, and a liquidity crisis despite a recent $55M lender lifeline.